Evidence map›Paper›PMID 37206285›Full record

ArticleEJHaem2023

Systemic osteosclerosis associated with primary bone marrow B-cell lymphoma.

Shuji Ozaki, Tsutomu Iima, Etsuko Sekimoto, Hironobu Shibata, Toshio Shigekiyo, Yukio Higuchi, Takanori Hirose

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in EJHaem, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Shuji OzakiDepartment of Hematology Tokushima Prefecture Central Hospital Tokushima Japan.ORCID https://orcid.org/0000-0002-9808-0752
Tsutomu IimaDepartment of Cardiovascular Medicine Tokushima Prefecture Central Hospital Tokushima Japan.
Etsuko SekimotoDepartment of Hematology Tokushima Prefecture Central Hospital Tokushima Japan.
Hironobu ShibataDepartment of Hematology Tokushima Prefecture Central Hospital Tokushima Japan.
Toshio ShigekiyoDepartment of Hematology Tokushima Prefecture Central Hospital Tokushima Japan.
Yukio HiguchiDepartment of Orthopedic Surgery Tokushima Prefecture Central Hospital Tokushima Japan.
Takanori HiroseDepartment of Diagnostic Pathology Tokushima Prefecture Central Hospital Tokushima Japan.
Tokushima Prefectural Central Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Systemic osteosclerosis is a rare complication of hematological malignancies. Primary myelofibrosis and acute megakaryocytic leukemia are known as underlying diseases; however, lymphoid tumors have rarely been reported. Here we describe a case of a 50-year-old man with severe systemic osteosclerosis associated with primary bone marrow B-cell lymphoma. Analysis of bone metabolic markers revealed a high turnover of bone metabolism and an increase in serum osteoprotegerin levels. These results suggest the involvement of osteoprotegerin in the pathogenesis of osteosclerosis associated with hematological malignancies.

Indexed as

osteoprotegerinosteosclerosisprimary bone marrow B‐cell lymphoma

Identifiers

PMID37206285
PMCPMC10188472
OpenAlexW4319319085

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.